Literature DB >> 24140065

Description and predictive factors of infection in patients with chronic kidney disease admitted to the critical care unit.

Damien Contou1, Géraldine d'Ythurbide2, Jonathan Messika1, Christophe Ridel2, Antoine Parrot1, Michel Djibré1, Alexandre Hertig2, Eric Rondeau2, Muriel Fartoukh3.   

Abstract

OBJECTIVES: To describe the spectrum of infection and multidrug-resistant bacterial colonization, and to identify early predictors of infection in patients with chronic kidney disease (CKD) admitted to the critical care unit (CCU).
METHODS: A 7-month observational prospective single-centre study in a French university hospital.
RESULTS: 791 patients were admitted to the CCU, 135 of whom (17%) had severe CKD. Among these, 41 (30%) were infected on admission. Infection was microbiologically documented in 32 patients (78%), of which 7 (22%) were related to Pseudomonas aeruginosa. There was no infection related to extended-spectrum β-lactamase-producing enterobacteriaceae despite a 12% carriage rate on admission. A temperature ≥37.6 °C and a leukocyte count >12.000/mm³ were specific but poorly sensitive of infection (91% and 80%, and 45% and 39%, respectively). Using the threshold of 0.85 ng/ml, procalcitonin was a strong independent predictor of infection on admission (OR 12.8, 95% CI 4.4-37.3). Age (≥60 years) and the cause of CKD were two other predictors.
CONCLUSIONS: Infection accounts for one-third of CCU admissions in CKD patients, with a high prevalence of P. aeruginosa. The usual diagnostic criteria are inaccurate for diagnosing infection in this population. A procalcitonin ≥0.85 ng/ml might be helpful for early identifying CKD patients with infection.
Copyright © 2013 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic kidney disease; Epidemiology; Fever; Haemodialysis; Infection; Intensive care unit; Multidrug-resistant bacterial colonization; Procalcitonin

Mesh:

Year:  2013        PMID: 24140065     DOI: 10.1016/j.jinf.2013.10.003

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  4 in total

1.  Procalcitonin for the differential diagnosis of infectious and non-infectious systemic inflammatory response syndrome after cardiac surgery.

Authors:  Dong Zhao; Jianxin Zhou; Go Haraguchi; Hirokuni Arai; Chieko Mitaka
Journal:  J Intensive Care       Date:  2014-06-03

2.  Diagnostic value of procalcitonin for bacterial infections in patients undergoing hemodialysis: a systematic review and meta-analysis.

Authors:  Mei Tao; Danna Zheng; Xudong Liang; Qiang He; Wei Zhang
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

3.  Procalcitonin in bloodstream infections: beyond its role as a marker of clinical algorithm to reduce antimicrobial overuse.

Authors:  Yong Kyun Kim
Journal:  Korean J Intern Med       Date:  2017-12-28       Impact factor: 2.884

4.  The Relationship between Serum Procalcitonin and Dialysis Adequacy in Peritoneal Dialysis Patients.

Authors:  Benyong Wang; Chan Gao; Qi Chen; Ming Wang; Xiao Fei; Ning Zhao
Journal:  Iran J Public Health       Date:  2021-03       Impact factor: 1.429

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.